A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes
Male
0301 basic medicine
Epstein-Barr Virus Infections
Chemotaxis
T-Lymphocytes
FOS: Clinical medicine
Immunology
Immunologic Deficiency Syndromes
Intracellular Signaling Peptides and Proteins
Dendritic Cells
Protein Serine-Threonine Kinases
Antibodies, Viral
Antibodies, Bacterial
3. Good health
Killer Cells, Natural
03 medical and health sciences
Mutation
Cell Adhesion
Cytokines
Humans
Original Article
Transcriptome
Tuberculosis, Pulmonary
DOI:
10.1007/s10875-021-01115-2
Publication Date:
2021-08-24T09:04:20Z
AUTHORS (28)
ABSTRACT
Human serine/threonine kinase 4 (STK4) deficiency is a rare, autosomal recessive genetic disorder leading to combined immunodeficiency; however, the extent which immune signaling and host defense are impaired unclear. We assessed functional consequences of novel, homozygous nonsense STK4 mutation (NM_006282.2:c.871C > T, p.Arg291*) identified in pediatric patient by comparing his innate adaptive cell-mediated humoral responses with those three heterozygous relatives unrelated controls.The etiology was verified whole genome Sanger sequencing. gene protein expression measured quantitative RT-PCR immunoblotting, respectively. Cellular abnormalities were high-throughput RT-RCR, RNA-Seq, ELISA, flow cytometry. Antibody ELISA phage immunoprecipitation-sequencing.The exhibited partial loss complete function recurrent viral bacterial infections, notably persistent Epstein-Barr virus viremia pulmonary tuberculosis. molecular analyses revealed abnormal fractions T cell subsets, plasmacytoid dendritic cells, NK cells. The transcriptional patient's blood PBMC samples indicated dysregulated interferon signaling, immunity, increased apoptosis as well regulation cytokine-induced adhesion leukocyte chemotaxis genes. Nonetheless, had detectable vaccine-specific antibodies IgG various pathogens, consistent normal CD19 + B fraction, albeit distinctive antibody repertoire, largely driven herpes antigens.Patients can exhibit broad impairment extending beyond lymphoid
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (60)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....